Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: scott dier who wrote (940)	3/16/1998 3:23:00 PM
From: cargox	Read Replies (3) \| Respond to of 8117

Pyng Technologies Corp PYT Shares issued 7,677,856 Mar 13 close $5.85 Mon 16 Mar 98 News Release Mr Michael Jacobs reports The company wishes to address several media rumours concerning the company and the FAST 1 system. These rumours have been brought to the company's attention by the VSE. First, it was rumoured that the FAST 1 system will be featured on an undetermined NBC television program. This rumour has been circulating on the Internet and the company has no knowledge either of its source or its truthfulness. Secondly, a rumour concerning a feature article to appear in Bloomberg is apparently also circulating. Mr Jacobs was interviewed by the Bloomberg news service in late February. Any publication concerning this interview by Bloomberg is not a matter within the control of the company. Mr Jacobs also reports The FAST 1 Adult Intraosseous Infusion System has received formal recognition from the FDS's Office of Device Evaluation in its annual report for the fiscal year 1997 as a significant medical breakthrough. Thirty-five devices have been recognized by the ODE in several categories out of 20,000 submissions received and reviewed. The ODE recognizes these devices, including the FAST 1 as "significant medical breakthroughs because they are first of a kind, eg, they use a new technology or energy source, or they provide a major diagnostic or therapeutic advancement, such as reducing hospital stays, replacing the need for surgical intervention and reducing the time needed for diagnostic determination." The FAST 1 is the world's first adult intraosseous infusion system approved by the US FDA. Pyng has just been advised by the FDS Office of Device Evaluation that its annual report is available on the Internet at the FDA website (www.fda.gov/cdrh). Mr Jacobs also reports The FAST 1 Intraosseous Infusion System produced by the company's subsidiary, Pyng Medical Corp, has been successfully used on a conscious, live human subject. The FAST 1 was designed to achieve fast, reliable vascular access under emergency conditions in the pre-hospital environment. Pyng Medical recently completed training of emergency physicians at University of Maryland Medical Centre. Following the training, Dr Tom Stair, research director, the University of Maryland School of Medicine, decided he wanted to know what the FAST 1 would feel like and volunteered to have it used on him. Dr Stair and a colleague developed a fast (60 seconds) procedure for anaesthetizing the skin over the sternal insertion site. This procedure is suitable for use by some paramedics. Using this freezing procedure, the FAST 1 system was used on Dr Stair. Fluids were rapidly infused into him. He experienced no pain. In fact, Dr Stair reported that the procedure caused less pain than giving blood. Daily follow-ups for the three days following the procedure showed no medical complications. Thanks to Dr Stair and colleagues, Pyng Medical has demonstrated that within 2.5 minutes or less, a paramedic can reliably and simply achieve vascular access in a conscious patient. This discovery means market penetration will likely be greater and faster than is predicted in the company's financial projections.

To: scott dier who wrote (940)	3/16/1998 3:26:00 PM
From: the Chief	Read Replies (3) \| Respond to of 8117

Well Scott you lost alot of credibility with me!! Here is the News Release. He who panic's is lost Pyng Technologies Corp PYT Shares issued 7677856 1998-03-13 close $5.85 Monday Mar 16 1998 Mr Michael Jacobs reports The company wishes to address several media rumours concerning the company and the FAST 1 system. These rumours have been brought to the company's attention by the VSE. First, it was rumoured that the FAST 1 system will be featured on an undetermined NBC television program. This rumour has been circulating on the Internet and the company has no knowledge either of its source or its truthfulness. Secondly, a rumour concerning a feature article to appear in Bloomberg is apparently also circulating. Mr Jacobs was interviewed by the Bloomberg news service in late February. Any publication concerning this interview by Bloomberg is not a matter within the control of the company. Mr Jacobs also reports The FAST 1 Adult Intraosseous Infusion System has received formal recognition from the FDS's Office of Device Evaluation in its annual report for the fiscal year 1997 as a significant medical breakthrough. Thirty-five devices have been recognized by the ODE in several categories out of 20,000 submissions received and reviewed. The ODE recognizes these devices, including the FAST 1 as "significant medical breakthroughs because they are first of a kind, eg, they use a new technology or energy source, or they provide a major diagnostic or therapeutic advancement, such as reducing hospital stays, replacing the need for surgical intervention and reducing the time needed for diagnostic determination." The FAST 1 is the world's first adult intraosseous infusion system approved by the US FDA. Pyng has just been advised by the FDS Office of Device Evaluation that its annual report is available on the Internet at the FDA website (www.fda.gov/cdrh). Mr Jacobs also reports The FAST 1 Intraosseous Infusion System produced by the company's subsidiary, Pyng Medical Corp, has been successfully used on a conscious, live human subject. The FAST 1 was designed to achieve fast, reliable vascular access under emergency conditions in the pre-hospital environment. Pyng Medical recently completed training of emergency physicians at University of Maryland Medical Centre. Following the training, Dr Tom Stair, research director, the University of Maryland School of Medicine, decided he wanted to know what the FAST 1 would feel like and volunteered to have it used on him. Dr Stair and a colleague developed a fast (60 seconds) procedure for anaesthetizing the skin over the sternal insertion site. This procedure is suitable for use by some paramedics. Using this freezing procedure, the FAST 1 system was used on Dr Stair. Fluids were rapidly infused into him. He experienced no pain. In fact, Dr Stair reported that the procedure caused less pain than giving blood. Daily follow-ups for the three days following the procedure showed no medical complications. Thanks to Dr Stair and colleagues, Pyng Medical has demonstrated that within 2.5 minutes or less, a paramedic can reliably and simply achieve vascular access in a conscious patient. This discovery means market penetration will likely be greater and faster than is predicted in the company's financial projections. (c) Copyright 1997 Canjex Publishing Ltd. canada-stockwatch.com

To: scott dier who wrote (940)	3/16/1998 3:31:00 PM
From: the Chief	Respond to of 8117

On the contrary the stock should continue its rise based on its merits. The rumours were only here, in this forum, likely no where else. Thats why I like sticking to facts. Facts that we all understand. Get a grip, scott you are losing it!! the Chief

To: scott dier who wrote (940)	3/16/1998 3:48:00 PM
From: george eberting	Read Replies (1) \| Respond to of 8117

EXPECT THIS STOCK TO FREEFALL! If you believe this you're an idiot. This company has a truly remarkable product which is just on the verge of production. If you think the LACK of coverage by one network is going to cause the stock to tank, then let me have all you own at twice your cost!!! George E.